Oduah, E., Antonia, S. J., Clarke, J. J., Stinchcombe, T., Concepcion, J. R., Alder, L., Oswalt, C., D'Amico, T. A., Harpole, D. H., Tong, B. C., Salfity, H., Patel, K., Bevers, K., Hartwig, M. G., Wang, X. F., Ready, N. E. (2025). Safety, efficacy, and tumor immune microenvironment changes with neoadjuvant chemotherapy and cemiplimab with or without alirocumab in stage 1B-3A non-small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps8118